Physician profile
Jonathan D Stone
NPI 1285600452
$8,885.74
in general payments reported to CMS, 2019-2025
20 companies · $2,750 in 2025
The $2,750 reported for 2025 was more than what 89% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,276 · 2020: $400 · 2021: $1,031 · 2022: $1,593 · 2023: $151 · 2024: $685 · 2025: $2,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194 · Travel and Lodging: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.95 |
| Travel and Lodging | $1,391.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,128.36 | 2019-2025 | Proclaim, Durata |
| Nevro Corp. | $2,724.36 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $1,010.75 | 2019-2025 | Sprint Pns System |
| Boston Scientific Corporation | $792.92 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $490.30 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Foundation Fusion Solutions, LLC | $140.50 | 2020-2025 | |
| Abbvie INC. | $98.72 | 2024 | |
| Vertos Medical, INC. | $72.49 | 2023-2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $67.84 | 2022 | |
| Globus Medical, INC. | $65.85 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $61.83 | 2019-2021 | |
| Spinefrontier, INC. | $52.97 | 2025 | Nanofuse, Inspan, Sijfuse |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.29 | 2022 | |
| Pacira Therapeutics, INC. | $29.68 | 2021 | |
| Saluda Medical Americas, INC. | $26.41 | 2023 | Evoke Scs |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $22.70 | 2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $20.41 | 2024 | |
| Forte Bio-Pharma LLC | $19.89 | 2024 | Prolate, Nalocet |
| Medtronic USA, INC. | $15.76 | 2020 | |
| Assertio Therapeutics, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.